15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells

被引:11
作者
Chen, Siyan [1 ]
Liu, Chong [1 ]
Wang, Xiaoqian [1 ]
Li, Xiujin [1 ]
Chen, Yanling [1 ]
Tang, Nanhong [1 ]
机构
[1] Fujian Med Univ, Union Hosp, Fujian Inst Hepatobiliary Surg, Fuzhou 350001, Peoples R China
关键词
15d-PGJ(2); HBx; Liver cell; Apoptosis; VIRUS-X-PROTEIN; ACTIVATED RECEPTOR-GAMMA; HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; COX-2; EXPRESSION; UP-REGULATION; CANCER CELLS; PPAR-GAMMA; CYCLOOXYGENASE-2; PROLIFERATION;
D O I
10.1016/j.cbi.2014.02.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aims to investigate the inflammatory response characteristics of liver cells caused by HBV x protein (HBx) and the unique function of the PGE(2) inhibitor on HBx-positive liver cells. Tetrazolium blue colorimetric method, flow cytometry, and Western blot were performed to detect the proliferation, cycle, and apoptosis protein expression of HBx-positive HL7702 liver and control cells. The effect of the PGE2 inhibitor 15-Deoxy- Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) on the growth of HL7702-HBx was also observed. HBx induces the PGE2 accumulation in HL7702 liver cells and promotes their growth and inhibits their apoptosis. HL7702-HBx and HL7702 cells showed increased apoptosis rate, increased apoptosis-promoting protein expression, and reduced apoptosis-inhibiting protein expression under the effect of 15d-PGJ2, and the changes in HL7702-HBx cells were more significant than in HL7702 cells. HBx expression causes liver cells to be more sensitive to the apoptosis-promoting function of 15d-PGJ2. Therefore, the use of 15d-PGJ2 may be a new method for the prevention or treatment of inflammatory changes to cancer caused by HBV infection in liver cells. (c) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 38 条
[31]   Molecular functions and biological roles of hepatitis B virus x protein [J].
Tang, Hong ;
Oishi, Naoki ;
Kaneko, Shuichi ;
Murakami, Seishi .
CANCER SCIENCE, 2006, 97 (10) :977-983
[32]   Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1+/- Humans and Mice [J].
Tang, Jean Y. ;
Aszterbaum, Michelle ;
Athar, Mohammad ;
Barsanti, Franco ;
Cappola, Carol ;
Estevez, Nini ;
Hebert, Jennifer ;
Hwang, Jimmy ;
Khaimskiy, Yefim ;
Kim, Arianna ;
Lu, Ying ;
So, Po-Lin ;
Tang, Xiuwei ;
Kohn, Michael A. ;
McCulloch, Charles E. ;
Kopelovich, Levy ;
Bickers, David R. ;
Epstein, Ervin H., Jr. .
CANCER PREVENTION RESEARCH, 2010, 3 (01) :25-34
[33]   Therapeutic Potential of Peroxisome Proliferator-Activated Receptors in Chronic Inflammation and Colorectal Cancer [J].
Wang, Dingzhi ;
DuBois, Raymond N. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) :697-+
[34]  
Wu Qing, 2008, Zhonghua Yufang Yixue Zazhi, V42, P260
[35]   Potent Cell Growth Inhibitory Effects in Hepatitis B Virus X Protein Positive Hepatocellular Carcinoma Cells by the Selective Cyclooxygenase-2 Inhibitor Celecoxib [J].
Xie, Huahong ;
Gao, Liucun ;
Chai, Na ;
Song, Jiugang ;
Wang, Jun ;
Song, Zhenshun ;
Chen, Caiping ;
Pan, Yanglin ;
Zhao, Lina ;
Sun, Shiren ;
Wu, Kaichun ;
Feitelson, Mark A. ;
Liu, Jie ;
Fan, Daiming .
MOLECULAR CARCINOGENESIS, 2009, 48 (01) :56-65
[36]  
Zeng Xiang-Jian, 2012, Zhonghua Nan Ke Xue, V18, P692
[37]   Effects of hepatitis B virus X protein on the development of liver cancer [J].
Zhang, XD ;
Zhang, H ;
Ye, LH .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2006, 147 (02) :58-66
[38]   Additive Effects of Ulinastatin and Docetaxel on Growth of Breast Cancer Xenograft in Nude Mice and Expression of PGE2, IL-10, and IL-2 in Primary Breast Cancer Cells [J].
Zhong, Biao ;
Shen, Hongyan ;
Sun, Xin ;
Wang, Hong ;
Zhang, Yonghua ;
Sun, Zhijun .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (04) :252-258